XML 50 R38.htm IDEA: XBRL DOCUMENT v3.24.3

Business Segment Information Business Segment Information (Tables)

6 Months Ended

Sep. 30, 2024

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment [Table Text Block]

Financial information for each of our segments is presented in the following table:

						Three Months Ended September 30,												Six Months Ended September 30,
						2024						2023						2024						2023
Revenues:
Healthcare						$	944,230					$	870,056					$	1,845,451					$	1,688,930
AST						256,737						235,053						506,540						468,152
Life Sciences						127,945						133,095						256,423						264,508
Total revenues						$	1,328,912					$	1,238,204					$	2,608,414					$	2,421,590
Operating income (loss):
Healthcare						$	228,006					$	204,054					$	444,893					$	402,236
AST						109,902						110,783						227,616						220,373
Life Sciences						53,700						50,284						106,284						100,125
Corporate						(97,129)						(87,020)						(198,877)						(178,893)
Total operating income						$	294,479					$	278,101					$	579,916					$	543,841
Less: Adjustments
Amortization of acquired intangible assets (1)						$	67,971					$	69,846					$	135,632					$	133,938
Acquisition and integration related charges (2)						3,205						15,808						5,459						18,045
Tax restructuring (credits) costs (3)						(561)						—						(43)						9
Amortization of inventory and property "step up" to fair value (1)						1,402						917						2,793						2,539
Restructuring charges (credits) (4)						2,796						(23)						30,878						(4)
Income from operations						$	219,666					$	191,553					$	405,197					$	389,314

Revenue from External Customers by Products and Services [Table Text Block]

						Three Months Ended September 30,												Six Months Ended September 30,
						2024						2023						2024						2023
Healthcare:
Capital equipment						$	249,732					$	254,905					$	464,371					$	493,004
Consumables						341,707						306,025						685,061						586,306
Service						352,791						309,126						696,019						609,620
Total Healthcare Revenues						$	944,230					$	870,056					$	1,845,451					$	1,688,930
AST:
Capital equipment						$	8,805					$	1,754					$	9,893					$	2,628
Service						247,932						233,299						496,647						465,524
Total AST Revenues						$	256,737					$	235,053					$	506,540					$	468,152
Life Sciences:
Capital equipment						$	23,012					$	35,438					$	49,488					$	66,429
Consumables						72,125						59,409						141,943						121,107
Service						32,808						38,248						64,992						76,972
Total Life Sciences Revenues						$	127,945					$	133,095					$	256,423					$	264,508
Total Revenues						$	1,328,912					$	1,238,204					$	2,608,414					$	2,421,590

Revenue from External Customers by Geographic Areas [Table Text Block]

						Three Months Ended September 30,												Six Months Ended September 30,
						2024						2023						2024						2023
Revenues:
Ireland						$	22,802					$	20,399					$	44,996					$	40,435
United States						979,528						909,651						1,926,418						1,765,439
Other locations						326,582						308,154						637,000						615,716
Total Revenues						$	1,328,912					$	1,238,204					$	2,608,414					$	2,421,590

X

- Definition

Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 41
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-41

+ Details

Name:	us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-40

+ Details

Name:	us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration